Predrag Ostojić

615 total citations
31 papers, 428 citations indexed

About

Predrag Ostojić is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, Predrag Ostojić has authored 31 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 10 papers in Rheumatology and 8 papers in Dermatology. Recurrent topics in Predrag Ostojić's work include Systemic Sclerosis and Related Diseases (22 papers), Dermatologic Treatments and Research (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Predrag Ostojić is often cited by papers focused on Systemic Sclerosis and Related Diseases (22 papers), Dermatologic Treatments and Research (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Predrag Ostojić collaborates with scholars based in Serbia, Czechia and Italy. Predrag Ostojić's co-authors include Nemanja Damjanov, Nemanja Damjanov, Slavica Pavlov‐Dolijanović, Goran Radunović, Gordana Sušić, R Stojanović, Marco Matucci‐Cerinic, Milica Lazović, Kristin B. Highland and Richard M. Silver and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Rheumatology and Respiration.

In The Last Decade

Predrag Ostojić

30 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Predrag Ostojić Serbia 13 319 124 119 100 95 31 428
Vivek Nagaraja United States 11 340 1.1× 96 0.8× 158 1.3× 84 0.8× 50 0.5× 23 459
Véronique Le-Guern France 7 260 0.8× 141 1.1× 79 0.7× 132 1.3× 100 1.1× 7 364
Chiara M. Antonioli Italy 8 172 0.5× 69 0.6× 61 0.5× 60 0.6× 72 0.8× 13 299
Jasmin Raja Malaysia 12 210 0.7× 66 0.5× 42 0.4× 63 0.6× 140 1.5× 34 397
Amber Young United States 11 259 0.8× 66 0.5× 178 1.5× 91 0.9× 31 0.3× 13 364
Annica Nordin Sweden 12 165 0.5× 42 0.3× 111 0.9× 39 0.4× 79 0.8× 18 294
Sargunan Sockalingam Malaysia 13 91 0.3× 33 0.3× 27 0.2× 47 0.5× 197 2.1× 34 373
Liesbeth J J Beaart-van de Voorde Netherlands 11 115 0.4× 23 0.2× 24 0.2× 36 0.4× 192 2.0× 19 298
Rebecca Matro United States 10 140 0.4× 37 0.3× 132 1.1× 53 0.5× 40 0.4× 19 530
Khader N. Mustafa Jordan 10 36 0.1× 37 0.3× 35 0.3× 45 0.5× 134 1.4× 19 309

Countries citing papers authored by Predrag Ostojić

Since Specialization
Citations

This map shows the geographic impact of Predrag Ostojić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Predrag Ostojić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Predrag Ostojić more than expected).

Fields of papers citing papers by Predrag Ostojić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Predrag Ostojić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Predrag Ostojić. The network helps show where Predrag Ostojić may publish in the future.

Co-authorship network of co-authors of Predrag Ostojić

This figure shows the co-authorship network connecting the top 25 collaborators of Predrag Ostojić. A scholar is included among the top collaborators of Predrag Ostojić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Predrag Ostojić. Predrag Ostojić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gijón-Noguerón, Gabriel, P Bálint, Anastas Batalov, et al.. (2025). Terminologies and definitions used to classify patients with osteoarthritis: a scoping review. BMC Rheumatology. 9(1). 32–32. 2 indexed citations
2.
Ostojić, Predrag, et al.. (2024). Do Patients with Rheumatoid Arthritis Have an (In)Adequate Level of Physical Activity? A Latent Class Analysis Approach. Life. 14(12). 1600–1600. 1 indexed citations
3.
Ostojić, Predrag & Slavica Pavlov‐Dolijanović. (2018). Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab. Zeitschrift für Rheumatologie. 77(5). 412–415. 6 indexed citations
4.
Ostojić, Predrag, et al.. (2018). Neurological and electroneurography findings in patients with systemic sclerosis and symptoms of neuropathic pain in extremities. Acta Neurologica Belgica. 121(1). 205–209. 5 indexed citations
5.
Pavlov‐Dolijanović, Slavica, et al.. (2018). Long-term effects of immunosuppressive therapy on lung function in scleroderma patients. Clinical Rheumatology. 37(11). 3043–3050. 6 indexed citations
6.
Ostojić, Predrag, et al.. (2017). Managing refractory cryoglobulinemic vasculitis: challenges and solutions. Journal of Inflammation Research. Volume 10. 49–54. 18 indexed citations
7.
8.
Ostojić, Predrag, et al.. (2015). Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis. Zeitschrift für Rheumatologie. 75(7). 716–722. 6 indexed citations
9.
Ostojić, Predrag, et al.. (2013). Restless legs syndrome in patients with systemic sclerosis. Zeitschrift für Rheumatologie. 72(6). 590–593. 7 indexed citations
10.
Ostojić, Predrag. (2012). Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil. Rheumatology International. 34(1). 145–147. 8 indexed citations
11.
Ostojić, Predrag, et al.. (2012). AB0566 Improved efficacy of rituximab in rheumatoid arthritis when administered regularly at six-month intervals – data from the serbian registry (NARASS). Annals of the Rheumatic Diseases. 71. 670–670. 1 indexed citations
12.
Ivanović, Branislava, et al.. (2011). Which Factors Impact Myocardial Function in Systemic Sclerosis?. Echocardiography. 29(3). 307–317. 12 indexed citations
13.
Ostojić, Predrag & Nemanja Damjanov. (2010). Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis. Rheumatology International. 31(8). 1051–1054. 13 indexed citations
14.
Ostojić, Predrag & Nemanja Damjanov. (2008). Indices of the Scleroderma Assessment Questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time. Joint Bone Spine. 75(3). 286–290. 12 indexed citations
15.
Damjanov, Nemanja, Predrag Ostojić, O. Kaloudi, et al.. (2008). Induced Sputum in Systemic Sclerosis Interstitial Lung Disease: Comparison to Healthy Controls and Bronchoalveolar Lavage. Respiration. 78(1). 56–62. 11 indexed citations
16.
Ostojić, Predrag, Marco Matucci‐Cerinic, Richard M. Silver, Kristin B. Highland, & Nemanja Damjanov. (2007). Interstitial Lung Disease in Systemic Sclerosis. Lung. 185(4). 211–220. 26 indexed citations
17.
Ostojić, Predrag & Nemanja Damjanov. (2006). Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy. Clinical Rheumatology. 25(6). 819–821. 10 indexed citations
18.
19.
Ostojić, Predrag & Nemanja Damjanov. (2006). The Scleroderma Assessment Questionnaire (SAQ). Zeitschrift für Rheumatologie. 65(2). 168–75. 17 indexed citations
20.
Ostojić, Predrag & Nemanja Damjanov. (2005). Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clinical Rheumatology. 25(4). 453–457. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek Nagaraja Breakdown of academic impact, for papers by Véronique Le-Guern Breakdown of academic impact, for papers by Chiara M. Antonioli Breakdown of academic impact, for papers by Jasmin Raja Breakdown of academic impact, for papers by Amber Young Breakdown of academic impact, for papers by Annica Nordin Breakdown of academic impact, for papers by Sargunan Sockalingam Breakdown of academic impact, for papers by Liesbeth J J Beaart-van de Voorde Breakdown of academic impact, for papers by Rebecca Matro Breakdown of academic impact, for papers by Khader N. Mustafa
Rankless by CCL
2026